Skip to main content
. 2022 Mar 24;95(1134):20211014. doi: 10.1259/bjr.20211014

Figure 6.

Figure 6.

( a) ROC curve of full-volume radiomics models, clinical model, and the combined model.( b) The developed clinical-full-volume radiomics nomogram for predicting KRAS mutation status. (c) The calibration curves of the integrated nomogram to predict KRAS mutation in the training and test cohorts. (d) DCA of the clinical features and the nomogram (full-volume radiomics features and clinical features). CEA, carcinoembryonic antigen; DCA, decision curve analysis; ROC, reeiver operating characteristic.